Clinical Trials
2 trialsNCT01787487 2026-03-31
Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00381693 2011-04-21
Azacitidine in Treating Patients With Myelofibrosis
Mayo Clinic
Phase 2 Terminated